Skip to main content
XENE filings

Corporate insider profile

Christopher John Kenney Filing Activity

Latest reported as Chief Medical Officer of Xenon Pharmaceuticals Inc. (XENE).

Purchase filings
0
Reported companies
1
Net open-market value
-$425,829.33
Latest transaction
Aug 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 28, 2026Xenon Pharmaceuticals Inc. (XENE)Chief Medical OfficerSale7,068$60.25$425,829